Athira Pharma (ATHA)
US Market

Athira Pharma (ATHA) Financial Statements


Athira Pharma Financial Overview

Athira Pharma's market cap is currently ―. The company's EPS TTM is $-2.175; its P/E ratio is -1.71; Athira Pharma is scheduled to report earnings on March 23, 2023, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -21.17M$ -24.83M$ -20.98M$ -16.34M$ -15.67M
EBITDA$ -20.94M$ -24.61M$ -20.82M$ -16.21M$ -15.55M
Net Income Common Stockholders$ -20.74M$ -24.34M$ -20.98M$ -16.31M$ -15.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 220.96M$ 252.40M$ 263.53M$ 253.76M$ 235.78M
Total Assets$ 274.19M$ 292.01M$ 313.00M$ 332.01M$ 347.33M
Total Debt$ 1.99M$ 2.06M$ 1.85M$ 1.92M$ 1.99M
Net Debt$ -218.97M$ -250.34M$ -261.68M$ -251.84M$ -233.79M
Total Liabilities$ 11.94M$ 11.45M$ 11.03M$ 10.92M$ 11.09M
Stockholders Equity$ 262.25M$ 280.56M$ 301.98M$ 321.08M$ 336.24M
Cash Flow-
Free Cash Flow$ -21.88M$ -18.74M$ -17.32M$ -19.20M$ -10.43M
Operating Cash Flow$ -21.64M$ -18.59M$ -16.57M$ -18.18M$ -10.30M
Investing Cash Flow$ 13.63M$ -4.46M$ 23.85M$ 21.37M$ -14.20M
Financing Cash Flow$ 0.00$ 297.00K$ 210.00K$ 13.00K$ 125.00K
Currency in USD

Athira Pharma Earnings and Revenue History

Athira Pharma Debt to Assets

Athira Pharma Cash Flow

Athira Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis